510(k) Report

510(k) · Cleared

Cleared

Siascope II

K023729510(k) TraditionalCleared Feb 3, 200389-day reviewClass II21 CFR 878.4580

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Astron Clinica Limited · PSN Light Based Imaging

Cleared on Feb 3, 2003 after an 89-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 3 later devices descend from it.

Decided
Feb 3, 2003
Review
89 days
Class
Class II
Product code
PSN
Recalls
None
Predicates
0

3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2008: 1 descendant cleared2007: 1 descendant cleared2021: 1 descendant cleared200020052010201520202025
  1. This deviceK023729 Siascope IIAstron Clinica Limited · 2003
  2. Descendant · cites it directly · 1 of its ownK062736 Siascope VAstron Clinica Limited · 2007
  3. Descendant · 2 generations on · 0 of its ownK201408 Demetra Analytics ToolkitBarco N.V. · 2021
  4. Descendant · cites it directly · 0 of its ownK080788 Vivascope System, Model 1500, 3000Lucid, Inc. · 2008

Most influential descendants

Showing 3 of 3 · See all
  • K062736Siascope VAstron Clinica Limited · 2007 · cites it directly1descendant
  • K201408Demetra Analytics ToolkitBarco N.V. · 2021 · 2 generations on0descendants
  • K080788Vivascope System, Model 1500, 3000Lucid, Inc. · 2008 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K023729Siascope IIAstron Clinica Limited2003—
+1K062736Siascope VAstron Clinica Limited2007—
+2K201408Demetra Analytics ToolkitBarco N.V.2021—
+1K080788Vivascope System, Model 1500, 3000Lucid, Inc.2008—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200810
202110
FIG. 1 — Lineage of K023729, 2003–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PSN device

  1. #1 K230448 DeepX DermoSight Dermatoscopescore 6.3 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K062736Siascope VAstron Clinica Limited20071
K080788Vivascope System, Model 1500, 3000Lucid, Inc.20080

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K062736 (Astron Clinica Limited, 2007) has gone furthest, with 1 descendant of its own.

How does its category compare?

All PSN devices

PSN Light Based Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · PSN

1in 2023

2007: 12008: 12018: 12019: 12021: 12022: 12023: 1
2007high 1 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSN

Too few PSN 510(k)s in any year since 2007 to give a median.

Recalls per year · PSN

No recall names PSN since 2007.

Adverse event reports per year · PSN

No MAUDE report names PSN since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20081—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20191—00
20200—00
20211—00
20221—00
20231—00
20240—00
20250—00
20260—0—

What is it indicated for?

SlAscope is a non-invasive skin analysis system, which provides a synthesized ‘image’ showing the relative location of blood collagen and pigment.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K023729: Siascope II.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K023729

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026